Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor
The κ-opioid receptor (KOR) is a member of the G protein-coupled receptor (GPCR) family, modulating cellular responses through transducers such as G proteins and β-arrestins. G-protein-biased KOR agonists aim to retain analgesic and antipruritic actions while limiting aversion and sedation. Aiming to inform G-biased KOR agonist design, we analyze signaling-relevant residues from structural and dynamic views. Here we show, using multiple complementary methods, shared residues that determine β-arrestin recruitment by nalfurafine and U-50,488H. Cryo-electron microscopy structures of the KOR-G<sub>i</sub> signaling complexes identify the ligand binding mode in the activated state. Vibrational spectroscopy reveals ligand-induced conformational changes. Cell-based mutant experiments pinpoint four amino acids (K227<sup>5.40</sup>, C286<sup>6.47</sup>, H291<sup>6.52</sup>, and Y312<sup>7.34</sup>; Ballesteros-Weinstein numbering is shown in superscript) that play crucial roles in β-arrestin recruitment. Furthermore, MD simulations revealed that the four mutants tend to adopt conformations with reduced β-arrestin recruitment activity. Our research findings provide a foundation for enhancing KOR-mediated therapeutic effects while minimizing unwanted side effects by targeting specific residues within the KOR ligand-binding pocket, including K227<sup>5.40</sup> and Y312<sup>7.34</sup>, which have previously been implicated in biased signaling.
Authors
- Ryo Nishikawa (ORCID: https://orcid.org/0000-0001-5617-8068)
- Akihisa Tokuda
- Shun Yokoi (ORCID: https://orcid.org/0000-0003-2684-3420)
- Hideki Kandori (ORCID: https://orcid.org/0000-0002-4922-1344)
- Hiroshi Nagase (ORCID: https://orcid.org/0000-0003-0428-3979)
- Mika Hirose (ORCID: https://orcid.org/0000-0001-8991-587X)
- Ayori Mitsutake (ORCID: https://orcid.org/0000-0002-4194-7255)
- Ryoji Kise (ORCID: https://orcid.org/0009-0000-6583-1719)
- Chiyo Suno-Ikeda
- Tomoyo Takai
- Asuka Inoue (ORCID: https://orcid.org/0000-0003-0805-4049)
- Takayuki Kato (ORCID: https://orcid.org/0000-0002-8879-6685)
- Ryoji Suno (ORCID: https://orcid.org/0000-0003-2378-236X)
- Yukihiko Sugita (ORCID: https://orcid.org/0000-0001-6861-4840)
- Kota Katayama (ORCID: https://orcid.org/0000-0001-8498-4374)
- Seiya Iwata
- Eri Asai
- Takuya Kobayashi (ORCID: https://orcid.org/0000-0001-6270-1353)
- Akitoshi Inoue (ORCID: https://orcid.org/0000-0002-5432-4137)
- Tsuyoshi Saitoh (ORCID: https://orcid.org/0000-0001-6105-6292)
- Takaya Ogura
- Riko Suzuki (ORCID: https://orcid.org/0000-0002-9465-3832)
- Risako Katamoto
Institutions
- Kansai Medical University (JP)
- University of Tsukuba (JP)
- Meiji University (JP)
- Nagoya Institute of Technology (JP)
- Tohoku University (JP)
- Kyoto University (JP)
- Kyoto Pharmaceutical University (JP)
- Japan Agency for Medical Research and Development (JP)
- Protein Research Foundation (JP)
- The University of Osaka (JP)
- Tsukuba International University (JP)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1038/s41467-025-64882-1
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Foundation for Applied Enzymology
- Japan Agency for Medical Research and Development
- Meiji University
- Ministry of Education, Culture, Sports, Science and Technology
- University of Tsukuba
- Kansai Medical University
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology
- JST-Mirai Program
- Moonshot Research and Development Program